Open AccessMonotherapy with a A2A Adenosine Receptor Antagonist Reduces Tumor Volume in a 4-NQO-induced Head and Neck Cancer (HNC) Mouse Model
Laryngo-rhino-otologiePeer ReviewedSonja Ludwig +72019Conference proceedings
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support